1. Home
  2. IMRN vs CISO Comparison

IMRN vs CISO Comparison

Compare IMRN & CISO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • CISO
  • Stock Information
  • Founded
  • IMRN 1994
  • CISO 2015
  • Country
  • IMRN Australia
  • CISO United States
  • Employees
  • IMRN N/A
  • CISO N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • CISO Computer Software: Prepackaged Software
  • Sector
  • IMRN Health Care
  • CISO Technology
  • Exchange
  • IMRN Nasdaq
  • CISO Nasdaq
  • Market Cap
  • IMRN 15.0M
  • CISO 12.5M
  • IPO Year
  • IMRN N/A
  • CISO N/A
  • Fundamental
  • Price
  • IMRN $2.11
  • CISO $1.55
  • Analyst Decision
  • IMRN Strong Buy
  • CISO
  • Analyst Count
  • IMRN 1
  • CISO 0
  • Target Price
  • IMRN $5.00
  • CISO N/A
  • AVG Volume (30 Days)
  • IMRN 6.2K
  • CISO 122.5K
  • Earning Date
  • IMRN 12-31-2024
  • CISO 11-18-2024
  • Dividend Yield
  • IMRN N/A
  • CISO N/A
  • EPS Growth
  • IMRN N/A
  • CISO N/A
  • EPS
  • IMRN N/A
  • CISO N/A
  • Revenue
  • IMRN $3,271,194.00
  • CISO $54,633,909.00
  • Revenue This Year
  • IMRN N/A
  • CISO $78.76
  • Revenue Next Year
  • IMRN N/A
  • CISO N/A
  • P/E Ratio
  • IMRN N/A
  • CISO N/A
  • Revenue Growth
  • IMRN 171.67
  • CISO 34.87
  • 52 Week Low
  • IMRN $1.59
  • CISO $0.26
  • 52 Week High
  • IMRN $5.96
  • CISO $3.60
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 52.87
  • CISO 59.64
  • Support Level
  • IMRN $2.05
  • CISO $1.50
  • Resistance Level
  • IMRN $2.23
  • CISO $1.73
  • Average True Range (ATR)
  • IMRN 0.16
  • CISO 0.19
  • MACD
  • IMRN 0.02
  • CISO -0.00
  • Stochastic Oscillator
  • IMRN 47.06
  • CISO 45.08

About IMRN Immuron Limited

Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About CISO CISO Global Inc.

CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.

Share on Social Networks: